SAN DIEGO, Oct. 31, 2011 /PRNewswire/ — Neurocrine Biosciences, Inc. (NASDAQ:NBIX) today announced its financial results for the quarter ended September 30, 2011.
For the third quarter of 2011, the Company reported net income of $31.4 million, or $0.56 per fully diluted share…
Popularity: 1% [?]

